Bioventus: Cash Flow Anchors The Bull Case Beyond A Potential Sale
Bioventus uses established-product cash flow to cut debt and fund launches, while its 2030 term loan extension and lower margin support its…
Equity Eagle NASDAQ
Bioventus Inc.
BVS
1 story
$1.2B Market cap · 2026-10-21
Equity Eagle 